XML 15 R19.htm IDEA: XBRL DOCUMENT v3.20.1
EQUITY INVESTMENT AND ROYALTIES - Schedule of Stock Options, Valuation Assumptions (Details) - Cell MedX Corp. [Member]
3 Months Ended
Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Risk-free rate (%) 0.29%
Expected stock price volatility (%) 183.00%
Expected dividend yield (%) 0.00%
Expected life of options (years) 2 years 9 months 29 days